Glow LifeTech (DE:9DO)
FRANKFURT:9DO
9DO Stock Chart & Stats
€0.02
€0.00(0.00%)
At close: 4:00 PM EST
€0.02
€0.00(0.00%)
Day’s Range― - ―
52-Week Range<€0.01 - €0.05
Previous CloseN/A
Volume0.00
Average Volume (3M)83.00
Market Cap
€5.34M
Enterprise Value€7.11M
Total Cash (Recent Filing)€1.59M
Total Debt (Recent Filing)€45.48K
Price to Earnings (P/E)―
Beta0.70
Next Earnings
Sep 01, 2026EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)<0.01
Shares Outstanding192,235,550
10 Day Avg. Volume0
30 Day Avg. Volume83
Financial Highlights & Ratios
PEG Ratio0.19
Price to Book (P/B)3.82
Price to Sales (P/S)5.04
P/FCF Ratio-87.53
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Bulls Say, Bears Say
Bulls Say
Accelerating Revenue GrowthMeaningful TTM revenue acceleration indicates stronger product adoption or market traction, which supports scaling. Sustained top-line growth reduces dependency on financing if margins continue improving and underpins longer-term path to profitability even while investments continue.
Low Leverage / Financial FlexibilityA low-debt capital structure preserves financial flexibility and reduces bankruptcy risk, giving management room to invest in R&D or commercialization. That structural strength supports endurance through cash burn phases and lowers refinancing pressure over the medium term.
Improving Free Cash Flow TrendMaterial improvement in free cash flow signals progress toward operational efficiency and a narrowing funding gap. If sustained, improved FCF reduces reliance on external capital and improves ability to self-fund growth initiatives and R&D over the next several quarters.
Bears Say
Ongoing Negative Cash GenerationPersistent negative operating cash flow indicates the core business still consumes cash, requiring external financing or reserve drawdowns. This structural cash burn raises dilution and refinancing risk until operations generate sustained positive cash flow.
Continued Unprofitable OperationsNegative operating profit and EBITDA show the business has not yet demonstrated sustainable unit economics. Continued losses compress returns and can impede investment prioritization, challenging the company’s ability to reach durable profitability without margin improvement.
Balance-Sheet Volatility / Past Negative EquityPrior episodes of negative equity and balance-sheet swings reveal potential vulnerability to recurring losses or financing shocks. This structural volatility can limit strategic options and increase creditor scrutiny if operating performance falters again.
Glow LifeTech News
9DO FAQ
What was Glow LifeTech’s price range in the past 12 months?
Glow LifeTech lowest stock price was <€0.01 and its highest was €0.05 in the past 12 months.
What is Glow LifeTech’s market cap?
Glow LifeTech’s market cap is €5.34M.
When is Glow LifeTech’s upcoming earnings report date?
Glow LifeTech’s upcoming earnings report date is Sep 01, 2026 which is in 78 days.
How were Glow LifeTech’s earnings last quarter?
Currently, no data Available
Is Glow LifeTech overvalued?
According to Wall Street analysts Glow LifeTech’s price is currently Overvalued.
Does Glow LifeTech pay dividends?
Glow LifeTech does not currently pay dividends.
What is Glow LifeTech’s EPS estimate?
Glow LifeTech’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Glow LifeTech have?
Glow LifeTech has 192,235,550 shares outstanding.
What happened to Glow LifeTech’s price movement after its last earnings report?
Currently, no data Available
Which hedge fund is a major shareholder of Glow LifeTech?
Currently, no hedge funds are holding shares in DE:9DO
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
Glow LifeTech
Glow Lifetech Corp. is a biotechnology enterprise based in North America, dedicated to the development and marketing of nutraceutical and cannabinoid-derived products. The company is actively commercializing two core technologies: MyCell Enhanced technology, which facilitates the optimal delivery of nutrients for both nutraceuticals and cannabis, and a Cannabis Smart Consumption System, designed to help users and patients store, track, manage, and consume cannabis products effectively. Glow Lifetech possesses exclusive rights throughout North America for the production, sale, and distribution of a specific micellization technology, applicable to cannabis and hemp-derived ingredients, curcumin, Vitamin K, and iron. A key aspect of their operations involves the advanced processing of ingredients, converting certain vitamins, nutraceuticals, and cannabis extracts into micellized forms. This process significantly boosts the bioavailability of fat-soluble compounds, ensuring near 100% absorption into the body and enhancing their compatibility with water. The company, founded in 2018, is headquartered in Toronto, Canada.
Technical Analysis
COSCIENS Biopharma
―
Kane Biotech
―
Quest Pharmatech
―
PreveCeutical Medical
―
PharmAla Biotech Holdings, Inc.
―
Options Prices
Currently, No data available
---